Pekin Hardy Strauss’s Elevance Health ELV Stock Holding History

Pekin Hardy Strauss’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Sell	4,030 -5,588	-58%	-$1.84M	0.12%	190
2025 Q4	$3.37M	Buy	9,618 +7,863	+448%	+$2.66M	0.31%	80
2025 Q3	$567K	Buy	+1,755	New	+$546K	0.06%	241
2025 Q1	–	Sell	-575	Closed	-$212K	–	373
2024 Q4	$212K	Buy	+575	New	+$241K	0.03%	328
2022 Q2	–	Sell	-840	Closed	-$413K	–	331
2022 Q1	$413K	Sell	840 -14,305	-94%	-$6.54M	0.05%	244
2021 Q4	$7.02M	Sell	15,145 -210	-1%	-$88.3K	0.95%	22
2021 Q3	$5.72M	Sell	15,355 -50	-0.3%	-$19K	0.82%	26
2021 Q2	$5.88M	Sell	15,405 -2,085	-12%	-$797K	0.82%	28
2021 Q1	$6.28M	Buy	+17,490	New	+$5.62M	0.99%	26

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Pekin Hardy Strauss's ELV Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its Elevance Health (ELV) stake by 58% in Q1 2026, selling an estimated $1.84M and leaving 4,030 shares worth $1.18M. The position accounts for 0.12% of the portfolio, ranked #190.

Pekin Hardy Strauss first reported a position in ELV in Q1 2021 and has held it in 9 quarters since. The position peaked at $7.02M in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Pekin Hardy Strauss held 4,030 shares of Elevance Health worth $1.18M as of Q1 2026.
Pekin Hardy Strauss sold 5,588 Elevance Health shares in Q1 2026, an estimated $1.84M.
Elevance Health made up 0.12% of Pekin Hardy Strauss's portfolio in Q1 2026, its #190 holding.
Pekin Hardy Strauss first reported a position in Elevance Health in Q1 2021 and has held it in 9 quarters since.
Pekin Hardy Strauss's Elevance Health position peaked at $7.02M in Q4 2021.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.